Next Article in Journal
Multi-Component Characterization and Quality Evaluation Strategy of Sarcandrae Herba by Combining Dual-Column Tandem HPLC Fingerprint and UPLC-Q-TOF-MS/MS
Previous Article in Journal
Combination Treatment of Timosaponin BII and Pirfenidone Attenuated Pulmonary Fibrosis Through Anti-Inflammatory and Anti-Fibrotic Process in Rodent Pulmonary Fibrosis Model and Cellular Epithelial–Mesenchymal Transition Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Steric Effects of N-Alkyl Group on the Base-Induced Nitrogen to Carbon Rearrangement of Orthogonally Protected N-Alkyl Arylsulphonamides

School of Chemistry and Biosciences, Faculty of Life Sciences, University of Bradford, Bradford BD7 1DP, UK
*
Author to whom correspondence should be addressed.
Molecules 2025, 30(8), 1823; https://doi.org/10.3390/molecules30081823
Submission received: 29 November 2024 / Revised: 4 April 2025 / Accepted: 15 April 2025 / Published: 18 April 2025
(This article belongs to the Section Organic Chemistry)

Abstract

:
The rearrangement of a total of 56 members of 22 series of orthogonally protected N-alkyl arylsulphonamides of general structure 4-XC6H4SO2NR1CO2R2 [X = H, CH3, F, Cl, Br, CH3O, CN, CF3 or C(CH3)3; R1 = CH3, CH2CH3, CH2CH2CH3, CH(CH3)2 or CH2CH(CH3)2; R2 = CH3, C2H5 or C(CH3)3] when treated with lithium di-isopropylamide in tetrahydrofuran at −78 °C has been studied. The competition between directed ortho metalated rearrangement, to form 4-X-2-(R2O2C)C6H3SO2NHR1 and the production of a substituted saccharin, is strongly influenced by the size of R1 and R2, especially in the series with X = CH3. When R1 = CH3 or to a lesser degree, C2H5, formation of the saccharin competes to a significant extent, especially when the migrating group is CO2CH3 or CO2C2H5. In contrast, when R1 is a larger alkyl group, particularly if it is branched at either the α- or β-carbon atom [CH(CH3)2 or CH2CH(CH3)2], the increased steric hindrance essentially prevents cyclisation, thus facilitating rearrangement to 4-X-2-(R2O2C)C6H3SO2NHR1 in high yield. The size of the migrating CO2R2 group also exerts an effect on the competition between the reactions: when R2 = C(CH3)3, clean rearrangement is possible even when R1 = CH3 in each series of X. These results have implications for further elaboration and rearrangement of 4-X-2-(R2O2C)C6H3SO2NHR1 in order to prepare substituted saccharins containing a 6-CO2R3 group.

1. Introduction

Aryl sulphonamides are a well-known class of compounds that have been applied in a variety of scientific endeavours for over a century. Prior to the advent of spectroscopic methods, the highly crystalline nature of several series of aryl sulphonamides was exploited to characterise amines by comparing the melting points of these derivatives with those of authentic samples [1]. Early synthetic applications of aryl sulphonamides include the preparation of unsymmetrical dialkyamines and trialkylamines by treatment of the derived anion with a reactive alkyl halide, thus obviating the undesirable di-alkylation that occurs when the parent amine is treated with the same alkylating agent [2,3] and facilitating successful efforts to prepare chiral tetralkylammonium salts [4,5]. A more general function of sulphonamides during the 20th and 21st centuries is as protecting groups, especially on nitrogen, as has been summarised in books reviewing their use [6,7]. Very recent efforts to design [8] and utilise [9,10] more selective protecting groups, as exemplified by 2,4,6-tris(trifluoromethyl)benzenesulphonamides, underline the contemporary significance of these species.
Exploitation of the biological activity of sulphonamides began with the discovery in the 1930s that sulphanilamide, which had first been prepared in 1908 [11], was the active form of the prodrug, Prontosil, which was effective as an antibiotic [12]. Sulphonamides and their derivatives are currently being applied in a wide range of pharmaceutical, medicinal and industrial contexts [13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31].
Many viable synthetic sequences involve the correct assumption that sulphonamides are generally inert to most basic reagents designed to modify functional groups elsewhere in the substrate. Thus, an attempt was made in this laboratory to elaborate the orthogonally protected pyridine-2-sulphonamide, 1, by deprotonating the stereogenic centre derived from valine with lithium di-isopropylamide (LDA) in tetrahydrofuran (THF) at −78 °C and methylating the anion with methyl iodide to produce 2, Scheme 1.
However, when the deprotonation was monitored by thin layer chromatography (TLC), it was found that a new product was formed essentially quantitatively before any methyl iodide had been added. This unexpected product was isolated after quenching with aqueous citric acid solution and characterised as 3, an isomer of 1 formed by directed ortho metalation (DOM) [32], followed by eventual migration of the CO2C(CH3)3 group originally attached to nitrogen to the adjacent “ortho” (3) position. Further investigation revealed that this intramolecular rearrangement could be induced in good yield (75–95%) for numerous CO2R, 4, and COR, 5, groups attached to nitrogen to give 6 and 7, respectively; Scheme 2 [33].
Intermolecular examples of DOM are known to occur for sulphonamides and related compounds, but typically under more forcing conditions with stronger bases, such as butyl lithium (BuLi) [32,34,35,36,37,38]. This intramolecular rearrangement actuated by the unusually mild base LDA was subsequently found to occur for carbocyclic sulphonamide derivatives, 8, with an N-CH(CH3)2 group and a representative 4-substituent [X = H, CH3, and CH3O] to give 9; Scheme 3. In contrast, the corresponding 4-nitrobenzenesulphonamide derivatives (X = NO2) did not undergo the rearrangement, thus revealing that this protecting group is compatible with modifications induced by LDA elsewhere in the molecule [39].
Rearrangement of 10 to 11 was feasible even if the migrating group contained an acidic hydrogen atom, provided excess LDA was used and the alkyl group was branched at the β- or γ-position to provide sufficient steric hindrance to prevent deprotonation at the α-position or nucleophilic attack at the carbonyl group from pre-empting DOM. Thus, in the 4-CH3C6H4SO2NR1COR2 series, COCH(CH3)2, COCH2CH(CH3)2 and COCH2C(CH3)3 groups migrated in fair to excellent yield (50–98%) when R1 = CH3 or CH(CH3)2; in contrast, the analogous derivatives containing COCH3 and COCH2CH2CH3 groups underwent predominant cleavage or decomposition; Scheme 4 [40]. The significance of these successful rearrangements when R2 contained acidic α-protons but also had branching at the β- or γ-carbon was further highlighted when attempts to replicate the process with BuLi substituted for LDA gave extensive cleavage or decomposition.
When the product of the first rearrangement was carboalkoxylated and treated with LDA, migration of a second CO2R2 group occurred to the other ortho position with eventual formation of a substituted saccharin, thus underlining the synthetic potential of this novel process [40]. The formation of the same product, regardless of the order in which the CO2R1 and CO2R2 groups migrate, has implications for the mechanism of this ‘double’ rearrangement. When the larger CO2C(CH3)3 group migrates first, cyclisation of the second organolithium species, 16, gives an intermediate, 17, which may directly expel the reasonable leaving group, CH3O, to give the saccharin, 18; Scheme 5.
When the smaller CO2CH3 group migrates first, an analogous mechanism would yield a saccharin, 24, containing a CO2CH3 substituent by elimination of the poor leaving group, (CH3)3CO, from the anion, 23, formed from the second organolithium species, 22. This process is pre-empted by formation of 18, possibly by ring opening of 23 to 25, followed by cyclisation to 17 and elimination of CH3O to give 18; Scheme 6. Alternatively, 25 might undergo protonation during the workup, to form a species with two ortho CO2R substituents, which would then eliminate the smaller ROH to form 18.
When a few representative homologues and analogues of 19 containing an N-methyl or N-ethyl group were rearranged, unexpected by-products were sometimes found, thus limiting the synthetic route to saccharins corresponding to 18. Consequently, this systematic survey of the influence of the size and structure of the N-alkyl group on the rearrangement of 22 series of 4-XC6H4SO2NR1CO2R2 derivatives was initiated in order to delineate the scope of the first step in the route illustrated in Scheme 5 and Scheme 6. Another objective was to investigate the influence, if any, of a variety of substituents, X, in the 4-position of the aryl group.

2. Results

Since less hindered members of the ArSO2NR1COR2 series tend to undergo cleavage of the N-C bond to give after workup the parent sulphonamide, ArSO2NHR1, [40], treatment of the analogous ArSO2NR1CO2R2, 26, with LDA at −78 °C might have been expected to give similar undesirable by-products. However, when the least hindered member of the series, 4-CH3SO2N(CH3)CO2CH3, was investigated, 1H NMR analysis of the crude product revealed approximately equal proportions of 27 (X = R1 = R2 = CH3, Scheme 7), formed by the desired rearrangement, and another 1,2,4-trisubstituted benzene, which gave no signal corresponding to either a methyl ester or an N-H. This product was isolated and characterised as the N-alkyl saccharin, 28 (X = R1 = CH3). Similarly, when the higher homologue with R1 = C2H5 and R2 = CH3 was studied, a smaller proportion (~20%) of the N-ethyl saccharin, 28, X = CH3, R1 = C2H5, was obtained, together with the desired major product, 27, R1 = C2H5, X = R2 = CH3.
The unexpectedly facile formation of a saccharin in these cases when R1 and R2 are both small may appear at first sight to be advantageous. However, further derivatisation of 28, to permit the second rearrangement and formation of N-alkyl saccharins with a 6-carboalkoxy substituent as shown in Scheme 5 and Scheme 6 would be difficult.
In order to establish which N-alkyl groups are compatible with clean rearrangement of 26 to 27, without formation of 28, 22 series of 4-XC6H4SO2NR1CO2R2 were prepared from the corresponding sulphonyl chlorides, 29, via the requisite XC6H4SO2NHR1 parent compounds, 30, by the synthetic routes summarised in Scheme 8. Each of these 56 derivatives was then treated with LDA under identical conditions (2 equivalents with a reaction time of 2 min before quenching with aqueous citric acid solution).
Table 1, Table 2 and Table 3 summarise the competition between intramolecular rearrangement and cyclisation (to form 27 and 28, respectively, Scheme 7). Initial work focused on five series with X = 4-CH3, Table 1, so as to investigate the influence of a wide range of N-alkyl groups. Once the trends in these series had been established, a less extensive set of substrates with X = H was studied, in which the N-alkyl group was chosen to give the greatest or smallest proportion of cyclisation, Table 2. Finally, a further 14 series with a wide range of 4-substituents [X = F, Cl, Br, CH3O, CF3, CN or C(CH3)3] were also investigated to establish that the trends found in the series with X = CH3 and H were general and to ascertain whether any specific X suppressed or favoured saccharin formation, Table 3.

3. Discussion

The data in Table 1, Table 2 and Table 3 reveal that the size and structure of the N-alkyl (R1) and the carboalkoxy group (CO2R2) each exert an influence on the competition between rearrangement and cyclisation, as does the nature of a substituent (X) in the 4-position of the aromatic ring. These results can be interpreted by considering the effect of R1, R2, and X on the competing reactions of the intermediate anion, 32, formed by cyclisation of the organolithium species, 31; Scheme 9.
The following trends are evident from Table 1.
Firstly, when R1 = CH3, the undesirable cyclisation occurs to a considerable extent when the migrating group is either CO2CH3 or CO2C2H5 (ratio of rearrangement to cyclisation of 1:1.1 or 2:1, respectively). The corresponding ratios for the next higher homologues with R1 = C2H5 are significantly greater (4:1 and 19:1, respectively). Extension of the length of the N-alkyl group to CH3CH2CH2 continues this effect, but cyclisation still competes to a minor extent when R2 = CH3 (ratio of 20:1), though less so when R2 = C2H5 (ratio of 50:1).
Secondly, the size of R2 in the migrating CO2R2 group also influences the competition. This effect is evident when R1 = CH3, for which the ratio of rearrangement to cyclisation increases from 1:1.1 when R2 = CH3 to 2:1 when R2 = C2H5. A stronger effect is evident in the series with R2 = C2H5, for which the ratio is 4:1 or 19:1, respectively, when R2 = CH3 or C2H5, presumably because, in the latter case, the combined effect of steric hindrance induced by two C2H5 groups almost suppresses cyclisation. Furthermore, branching of R2 has such a profound effect that cyclisation is effectively pre-empted, even when R1 = CH3, in the series with R2 = C(CH3)3. This trend is logically interpreted on the basis of the mechanism in Scheme 9: elimination of CH3O, and to a lesser degree, C2H5O, from the anion 32 is easier than expulsion of the much poorer leaving group, (CH3)3CO. This ‘electronic’ effect should reinforce the steric influence of the bulkier R2 group, which would be expected to favour ring opening to 33 by C-N cleavage, rather than loss of R2O. This interpretation concurs with the explanation summarised in Scheme 6. One immediate and highly significant implication of this finding is that it would be advisable to migrate the CO2C(CH3)3 group in the first rearrangement, followed by either CO2CH3 or CO2C2H5 in the second rearrangement, if it is desired to prepare an N-methyl or N-ethyl saccharin corresponding to 18, Scheme 5.
Thirdly, branching at the α-carbon atom in the R1 group also effectively suppresses cyclisation (as was previously found in the formation of one example of 18 with R1 = CH(CH3)2, in which the first of two consecutive reactions with LDA occurred without detectable cyclisation, but in which formation of a saccharin took place when the second derivative was treated with LDA [40]). In the series with R1 = CH(CH3)2, the ratio of rearrangement to cleavage is at least 50:1, even for the smallest migrating group, CO2CH3. Any cyclisation in the higher homologues with R2 = C2H5 or C(CH3)3 occurs to such a negligible extent that no sign of 28 could be detected in the 1H NMR spectra of the product, which appeared to be entirely 27 formed in isolated yields in the range 85–99%.
Fourthly, branching at the more distant β-carbon atom appears to be approximately equally effective in favouring rearrangement at the expense of cyclisation. Even when R2 = CH3, for which competition by the undesirable cyclisation does occur when R1 = CH3 or C2H5 (and, to a lesser extent, when R1 = n-C3H7), rearrangement occurs with very high selectivity in a ratio of 50:1 and an isolated yield of 90%.
These trends persist in the behaviour of the three series with X = H, Table 2, though the tendency to form a saccharin is reduced compared to that found for the analogous member of the corresponding series with X = CH3. Thus, when R1 = R2 = CH3, the ratio of 27:28 increases from 1.1:1 for X = CH3 to 9:1 for X = H. This result indicates that an electron-donating group in the aromatic ring favours cyclisation to 28, perhaps because it destabilises the anion, 33, formed by C-N cleavage of 32.
Similarly, the strong influence of the branched R1 groups, CH(CH3)2 and CH2CH(CH3)2 in effectively suppressing cyclisation when 4-CH3C6H4SO2NR1CO2R2 is treated with LDA, regardless of the nature of the migrating CO2R2 group, persists in the behaviour of the lower homologues, C6H5SO2NR1CO2R2. These observations, though hardly surprising, are important in establishing the generality of the influence of these branched R1 groups.
Further confirmation of these trends is found in the behaviour of the 14 series in which a variety of electron-withdrawing (X = F, Cl, Br, CF3 and CN) or electron-donating substituents (X = CH3O or (CH3)3C) are present in the 4-position, Table 3. In every case, the ratio of 27 to 28 increases sharply on progressing from R1 = CH3 to CH(CH3)2. Indeed, in most cases with R1 = CH(CH3)2, the proportion of saccharin formed was so small that it was difficult or impossible to detect in the standard 1H NMR spectrum. When these orthogonally protected sulphonamides were treated with LDA, essentially pure 27 was obtained in 80–95% isolated yield. Consequently, if it is desired to prepare 27 for further elaboration (for example, to synthesise substituted saccharins of general structure 18), it is desirable to select R1 = CH(CH3)2.
Another interesting trend is found in the results summarised in Table 3 in cases with R1 = R2 = CH3, for which formation of 28 is favoured when X = CH3 (as previously discussed). In each of the examples in Table 3, a significant, but smaller, proportion of 28 is formed. Moreover, in the halogeno series, the tendency to produce 27 declines as the electronegativity of the halogen increases (ratios of 27:28 = 17:1, 14:1 and 9:1, respectively, for X = F, Cl, and Br). This trend also is intelligible in terms of the mechanism suggested in Scheme 9. A more electron-withdrawing substituent (F, rather than Cl or Br) would be expected to stabilise the anion, 33, formed by C-N cleavage, thus favouring formation of 27. Similar effects are found with two other electron-withdrawing groups, i.e., when X = CN or CF3, which also favour rearrangement over cyclisation.
The case when X = CH3O, which is electron-withdrawing by the inductive effect but electron-donating by the mesomeric effect, is particularly interesting. Although the proportion of 27 is smaller than when X = CH3, it is greater than that for examples with any of the other substituents in Table 3. It is possible that any destabilising effect on the anion 33 caused by electron donation by the mesomeric effect is offset by a combination of the (weak) inductive effect and the possibility of “push–pull” interaction of the methoxy group with the S=O bonds in the sulphonamide moiety.
When X = C(CH3)3, cyclisation competes to some extent with rearrangement, as might have been expected because of the slight electron-donating effect of the large alkyl group. However, the effect is much less pronounced than when X = CH3. It appears, therefore, that formation of a saccharin is peculiarly favoured in the tosyl series.
Finally, attempts to explore other series with the even bulkier R1 group C(CH3)3 proved to be impracticable. Condensation of 4-CH3C6H4SO2Cl with (CH3)3CNH2 readily gave the desired parent sulphonamide, CH3C6H4SO2NHC(CH3)3, which could be effectively purified by recrystallisation. Unfortunately, treatment of 4-CH3C6H4SO2NHC(CH3)3 with [(CH3)3COCO]2O in the presence of 4-dimethylaminopyridine in dichloromethane gave no reaction, even after 48 h stirring under conditions in which other parent sulphonamides, including 4-CH3C6H4SO2NHCH2CH(CH3)2, gave 100% conversion to the N-CO2C(CH3)3 derivatives in a period of 10–60 min. Furthermore, attempts to prepare the lower homologue, 4-CH3C6H4SO2N[C(CH3)3]CO2CH3, were only partially successful, even after repeated treatment of 4-CH3C6H4SO2NHC(CH3)3 with NaH and ClCO2CH3, under conditions in which isomeric 4-CH3C6H4SO2N[CH2CH(CH3)2]CO2CH3 and 4-CH3C6H4SO2N[CH2CH(CH3)2]CO2C2H5 derivatives had been successfully made and purified.

4. Materials and Methods

Most of the parent sulphonamides, ArSO2NHR1, were prepared by dropwise addition of a dichloromethane solution of the corresponding commercial sulphonyl chloride, ArSO2Cl, to a magnetically stirred solution of a slight excess (1.1 equivalents) of the requisite amine, R1NH2 (for R1 = C3H7 or C4H9) in the presence of triethylamine (1.2–1.5 equivalents) as an acid scavenger, maintaining the temperature at 0–5 °C. Preparation of the lower homologues, with an N-CH3 or N-C2H5 group was achieved similarly, but with a solution of the parent amine in ethanol or water (in which case tetrahydrofuran was used instead of dichloromethane as the solvent). The addition typically required 20–40 min, after which stirring was continued until TLC showed that the reaction was complete. The crude sulphonamide was then isolated by a standard extractive procedure. In most cases, a solid product was obtained in close to quantitative yield; recrystallisation from ethanol/water (or in the case of 4-CH3C6H4SO2NHCH2CH2CH3, from light petroleum (bp: 40–60 °C)) gave pure product, usually in 75–85% yield.
The synthesis of the corresponding carbomethoxy and carboethoxy derivatives was achieved by dropwise addition under a nitrogen atmosphere of a solution of the parent sulphonamide in dry tetrahydrofuran to a magnetically stirred suspension in tetrahydrofuran of an excess (1.1–1.7 equivalents) of sodium hydride that had been washed by decantation with either petroleum ether or tetrahydrofuran to remove the mineral oil. Hydrogen gas was evolved. After allowing stirring to continue for 5–10 min, an excess (1.1–1.5 equivalents) of the requisite chloroformate was added in portions from a syringe. Once the reaction was complete, as revealed by TLC, the mixture was cautiously poured into cold water, and the product was isolated by extraction with dichloromethane. Solid products were purified by recrystallisation from ethanol/water; oils were purified by chromatography on silica, eluting with petroleum ether and ethyl acetate mixtures. Yields of crude product were normally at least 80%.
The carbo-tert-butoxy derivatives were prepared by stirring under a nitrogen atmosphere a dichloromethane solution of the parent sulphonamide and a slight excess (1.1–1.2 equivalents) of di-tert-butyldicarbonate in the presence of a catalytic quantity (0.02–0.05 equivalents) of 4-dimethylaminopyridine. Once TLC showed that the reaction was complete, water was added, followed by sufficient sodium carbonate solution (10% w/v) to raise the pH to 9. After stirring for a further 30–90 min, the dichloromethane layer was separated and the aqueous phase was extracted twice with dichloromethane. The combined organic phases were washed with dilute hydrochloric acid (to remove the 4-dimethylaminopyridine), dried (MgSO4), filtered and rotary evaporated to constant mass to give the crude product in 80–98% yield. Recrystallisation from ethanol/water gave pure product in 70–85% yield.
The following general procedure for treatment of the orthogonally protected sulphonamides with lithium di-isopropylamine was devised. A fresh solution of lithium di-isopropylamide was prepared by adding di-isopropylamine (0.65 mL) and THF (2.35 mL) to a septum-sealed flame-dried round-bottomed flask that had been flushed with nitrogen. The flask was cooled to −78 °C in a dry-ice/acetone bath and the contents were magnetically stirred as n-butyllithium (2.0 mL, 2.5 M in hexane) was added.
In a separate flask, the corresponding orthogonally protected sulphonamide (0.1–6.5 mmol) was dissolved in THF and cooled to −78 °C. Two equivalents of the lithium di-isopropylamine solution were transferred to the magnetically stirred sulphonamide solution by one of two methods. For small scale reactions (0.1–0.5 mmolar), the transfer was made by means of a disposable syringe, which was cooled by drawing up the solution and returning it to the cooled flask several times. For larger scale reactions (1.0–6.5 mmolar), the transfer was through a cannula by reducing the pressure in the flask containing the sulphonamide solution. Two minutes after the transfer was complete, the reaction was quenched by addition of aqueous citric acid solution. After allowing the reaction mixture to attain ambient temperature, the product was extracted with dichloromethane, dried (MgSO4), filtered, and rotary evaporated to constant mass to give the crude product at 70–99% yield. Solid products were purified by recrystallisation from ethanol/water; in cases where the reaction gave two products, the components were separated by chromatography on silica, eluting with petroleum ether and ethyl acetate mixtures.
Full characterisation data for all synthesised compounds are available in the Supplementary Materials.

5. Conclusions

Taken together, these trends lead to the following conclusions about the selection of the R1 and R2 groups if the undesirable cyclisation is to be avoided.
Firstly, if the N-alkyl group, R1, must be small, it is necessary to have a bulky R2 group, ideally C(CH3)3, for which rearrangement of CO2R2 generally occurs essentially without interference from cyclisation. If both R1 and R2 are small, cyclisation will compete with rearrangement for a wide range of substituents in the 4-position of the aromatic ring, thus reducing the yield and causing complications in purifying the desired product.
Secondly, if the migrating CO2R2 entity contains a small R2 group, it is desirable to choose a branched R1 substituent. In these cases, either CH(CH3)2 or CH2CH(CH3)2 appear to be equally viable.
Thirdly, although it might seem attractive to exploit the strong steric influence of R1 on the competition between the desired rearrangement and the unwanted cyclisation by choosing R1 = C(CH3)3, this option is impracticable because elaboration of the parent sulphonamide (which is easily prepared) to the required CO2R2 derivatives is much more difficult than for smaller R1 groups.
Finally, the two series with R1 = CH(CH3)2 or CH2CH(CH3)2 appear to offer the best prospects of securing clean rearrangement, irrespective of the nature of the migrating CO2R2 group and the nature of any substituent other than NO2 (for which rearrangement does not occur [39]). Analogues with smaller R1 groups (CH3 or C2H5) are more easily prepared, but do not always facilitate clean rearrangement without interference from cyclisation. The presence of the much bulkier C(CH3)3 group would probably lead to exclusive rearrangement, regardless of the nature of the migrating CO2R2 group, but steric hindrance is so pronounced in these cases that preparing the desired derivatives is much more difficult. The series with R1 = CH(CH3)2 or CH2CH(CH3)2 are advantageous in at least one analytical way: the presence of distinctive signals in the NMR spectra is useful (a one proton septet, and a six proton doublet, when R1 = CH(CH3)2, or a two proton doublet, a one proton nonet, and a six proton doublet, when R1 = CH2CH(CH3)2).

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules30081823/s1, further details of the synthetic procedures, including representative examples and characterisation data.

Author Contributions

Conceptualization, R.D.B.; methodology, W.H.C.M. and R.D.B.; validation, A.S., N.W.F., and J.E.; formal analysis, A.S., J.E., and N.W.F.; investigation, J.E., A.S., and R.D.B.; resources, R.D.B.; writing—original draft preparation, R.D.B.; writing—review and editing, R.D.B., A.S., and N.W.F.; visualisation, R.D.B., A.S., and N.W.F.; supervision, R.D.B., W.H.C.M., and A.S.; project administration, R.D.B., A.S., and N.W.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding author.

Acknowledgments

The assistance of Haseeb Ul-Rehman in recording the high-resolution mass spectra is gratefully acknowledged.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Vogel, A. Vogel’s Textbook of Practical Organic Chemistry, 4th ed.; Furniss, B.S., Hannaford, A.J., Rogers, V., Smith, P.W.G., Tatchell, A.R., Eds.; Longman Scientific and Technical: London, UK, 1978; pp. 1130–1131, 1228–1237. ISBN 0-582-46236-3. [Google Scholar]
  2. Hinsberg, O. Ueber die Bildung von Säureestern und Säureamiden bei Gegenwart von Wasser und Alkali. Ber. Dtsch. Chem. Ges. 1890, 23, 2962–2965. [Google Scholar] [CrossRef]
  3. Bel, J.A.L. Sur la dyssymètrie et la creation du pouvoir rotatoire dans les dèrivès alcooliques du chlorure d’ammonium Compt. Rendu 1891, 112, 724–726. [Google Scholar]
  4. Pope, W.J.; Peachey, S.J. Asymmetric Optically Active Nitrogen Compounds. Dextro- and Laevo-α-benzylphenylallylmethylammonium Iodides and Bromides. J. Chem. Soc. 1899, 75, 1127–1131. [Google Scholar] [CrossRef]
  5. Pope, W.J.; Read, J. Asymmetric quinquevalent nitrogen compounds of simple molecular constitution. J. Chem. Soc. 1912, 101, 519–529. [Google Scholar] [CrossRef]
  6. Kocienski, P.J. Protecting Groups, 3rd ed.; Thieme: Stuttgart, Germany, 2000. [Google Scholar]
  7. Wuts, P.G.M.; Greene, T.W. Protective Groups in Organic Synthesis, 4th ed.; Wiley: New York, NY, USA, 2007. [Google Scholar]
  8. Spieβ, P.; Sirvent, A.; Tiefenbrunner, I.; Sargueil, J.; Fernandes, A.J.; Arroyo-Bondia, A.; Meyrelles, R.; Just, D.; Prado-Roller, A.; Shaaban, S.; et al. Nms-Amides: An Amine Protecting Group with Unique Stability and Selectivity. Chem. A Eur. J. 2023, 29, e202301312. [Google Scholar] [CrossRef]
  9. Van Hoof, M.; Mayer, R.J.; Moran, J.; Leboef, D. Triflic Acid-Catalyzed Dehydrative Amination of 2-Arylethanols with Weak N-Nucleophiles in Hexafluoroisopropanol. Angew. Chem. Int. Ed. Engl. 2025, 64, e202417089. [Google Scholar] [CrossRef]
  10. Spieß, P.; Brześkiewicz, J.; Meyrelles, R.; Just, D.; Maulide, N. Deprotective Functionalization: A Direct Conversion of Nms-Amides to Carboxamides Using Carboxylic Acids. Angew. Chem. Int. Ed. 2024, 63, e202318304. [Google Scholar] [CrossRef]
  11. Gelmo, P. Über Sulfamide der p-Amidobenzolsulfonsäure. J. Prak. Chem. 1908, 77, 369–382. [Google Scholar] [CrossRef]
  12. Domagk, G. Ein beitrag zur chemotherapie der bakteriellen infektionen. Dtsch. Med. Wschr. 1935, 61, 250–253. [Google Scholar] [CrossRef]
  13. Owa, T.; Nagasu, K. Novel sulphonamide derivatives for the treatment of cancer. Expert Opin. Ther. Pat. 2000, 10, 1725–1740. [Google Scholar] [CrossRef]
  14. Abbate, F.; Casini, A.; Owa, T.; Scozzafava, A.; Supuran, C.T. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 217–223. [Google Scholar] [CrossRef] [PubMed]
  15. Ezabadi, R.R.; Camoutsis, C.; Zoumpoulakis, P.; Geronikaki, A.; Sokovic, M.; Glamocilija, J.; Ciric, A. Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents: Synthesis, biological evaluation, lipophilicity, and conformational studies. Bioorg. Med. Chem. 2008, 16, 1050–1161. [Google Scholar] [CrossRef]
  16. Torok, E.; Moran, E.; Cooke, F. Oxford Handbook of Infectious Diseases and Microbiology; Oxford University Press: Oxford, UK, 2009; ISBN 978-0-856925-1. [Google Scholar]
  17. Sippel, K.H.; Robbins, A.H.; Domsic, J.; Genis, C.; Agbandje-McKenna, M.; McKenna, R. High resolution structure of human carbonic anhydrase ii complexed with acetrazolamide reveals insights into inhibitor drug design. Acta Crystallogr. (Sect. F) 2009, 65, 992–995. [Google Scholar] [CrossRef]
  18. Mirian, M.; Zarghi, A.; Sadeghhi, S.; Tabaraki, P.; Tavallaee, M.; Dadrass, O.; Sadeghi-aliabadi, H. Synthesis and cytotoxic evaluation of some novel sulfonamide derivatives against a few human cancer cells. Iran. J. Pharm. Res. 2011, 10, 741–748. [Google Scholar] [CrossRef]
  19. Boechat, N.; Pinheiro, L.C.S.; Santos-Filho, O.A.; Silva, I. Design and Synthesis of New N-(5-Trifluoromethyl)-1H-1,2,4-triazol-3-yl Benzenesulfonamides as Possible Antimalarial Prototypes. Molecules 2011, 16, 8083–8097. [Google Scholar] [CrossRef]
  20. Alterio, V.; Di Fiore, A.; D’Ambrosio, K.; Supuran, C.T.; De Simone, G. Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? Chem. Rev. 2012, 112, 4421–4468. [Google Scholar] [CrossRef]
  21. Said, H.M.; Hagemann, C.; Carta, F.; Katzer, A.; Polat, B.; Staab, A.; Scozzafava, A.; Anacker, J.; Vince, G.H.; Flentje, M.; et al. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma. Bioorg. Med. Chem. 2013, 21, 3949–3957. [Google Scholar] [CrossRef]
  22. Shah, S.S.A.; Rivera, G.; Ashfaq, M. Recent Advances in Medicinal Chemistry of Sulfonamides. Rational Design as Anti-Tumoral, Anti-Bacterial and Anti-Inflammatory Agents. Mini. Rev. Med. Chem. 2013, 13, 70–86. [Google Scholar] [CrossRef]
  23. Lyden, P.; Pereira, B.; Chen, B.; Zhao, L.; Lamb, J.; Lei, I.-F.; Rajput, P. Direct Thrombin Inhibitor Argatroban Reduces Stroke Damage in 2 Different Models. Stroke 2014, 45, 896–899. [Google Scholar] [CrossRef]
  24. Ghorab, M.M.; Ragab, F.A.; Heiba, H.I.; El-Gazzar, M.G.; Zahran, S.S. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives. Eur. J. Med. Chem. 2015, 92, 682–692. [Google Scholar] [CrossRef]
  25. Zelder, F.; Sonnay, M.; Prieto, L. Antivitamins for Medicinal Applications. ChemBioChem 2015, 16, 1264–1278. [Google Scholar] [CrossRef] [PubMed]
  26. Chinthakindi, P.K.; Naicker, T.; Thota, N.; Govender, T.; Kruger, H.; Arvidsson, P.L. Sulfonimidamides in Medicinal and Agricultural Chemistry. Angew. Int. Ed. Engl. 2017, 56, 4100–4109. [Google Scholar] [CrossRef] [PubMed]
  27. Szumilak, M.; Stanczak, A. Cinnoline Scaffold—A Molecular Heart of Medicinal Chemistry? Molecules 2019, 24, 2271. [Google Scholar] [CrossRef] [PubMed]
  28. Jafarinejad, S.; Martin, W.H.C.; Ras, B.A.; Isreb, M.; Jacob, B.; Aziz, A.; Adoul, Z.; Lagnado, R.; Bowen, R.D.; Najafzadeh, M. The anticancer/cytotoxic effect of a novel gallic acid derivative in non-small cell lung carcinoma A549 cells and peripheral blood mononuclear cells from healthy individuals and lung cancer patients. BioFactors 2024, 50, 201–213. [Google Scholar] [CrossRef]
  29. Koyuncu, I.; Temiz, E.; Güler, E.M.; Durgun, M.; Yuksekdag, O.; Giovannuzzi, S.; Supuran, C.T. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors. ChemMedChem 2024, 19, e202300680. [Google Scholar] [CrossRef]
  30. Yerrabelly, J.R.; Bommagani, M.B.; Yerrabelly, H.; Mullaguri, S.C.; Kancha, R.K. Synthesis and anticancer activity of cinnoline sulphonamides and 4-heteroyclic derivatives: Cross-coupling approach. J. Heterocycl. Chem. 2024, 61, 958–970. [Google Scholar] [CrossRef]
  31. Siliveri, S.; Gudishetty, L.P.; Vaddiraju, N.; Kavali, J. Design, Synthesis, In Silico Molecular Docking, ADMET Studies, and Biological Evaluation of Novel Substituted Diphenyl Pyrazole Incorporated 1,2,3-Triazolyl Benzene Sulfonamides. Russ. J. Bioorg. Chem. 2024, 50, 1119–1132. [Google Scholar] [CrossRef]
  32. Snieckus, V. Directed ortho metalation. Tertiary amide and O-carbamate directors in synthetic strategies for polysubstituted aromatics. Chem. Rev. 1990, 90, 879–933. [Google Scholar] [CrossRef]
  33. Rushwinga, E.; Touray, H.K.; Bowen, R.D.; Gallagher, R.T.; Martin, W.H.C. Novel nitrogen to carbon rearrangement forming nicotinic acid sulfonamides. Tetrahedron Lett. 2013, 54, 4726–4728. [Google Scholar] [CrossRef]
  34. Watanabe, H.; Gay, R.; Hauser, C.R. Ortho metalation of N-substituted benzenesulfonamides by excess N-butyllithium. Condensation with carbonyl compounds. Cyclizations. J. Org. Chem. 1968, 33, 900–903. [Google Scholar] [CrossRef]
  35. Lombardino, J.G. Preparation of substituted 1,2-benzoisothiazolin-3-one 1,1-dioxides (o-benzoic sulfimides). J. Org. Chem. 1971, 36, 1843–1845. [Google Scholar] [CrossRef]
  36. Court, J.J.; Hlasta, D.J. Ortho versus adjacent-benzylic directed lithiations of substituted N,N-diethylbenzamides. Tetrahedron Lett. 1996, 37, 1335–1338. [Google Scholar] [CrossRef]
  37. Metallinos, C.; Nerdinger, S.; Snieckus, V. N-Cumyl Benzamide, Sulfonamide, and Aryl O-Carbamate Directed Metalation Groups. Mild Hydrolytic Lability for Facile Manipulation of Directed Ortho Metalation Derived Aromatics. Org. Lett. 1999, 1, 1183–1186. [Google Scholar] [CrossRef]
  38. MacNeil, S.L.; Familoni, O.B.; Snieckus, V. Selective Ortho and Benzylic Functionalization of Secondary and Tertiary p-Tolylsulfonamides. Ipso-Bromo Desilylation and Suzuki Cross-Coupling Reactions. J. Org. Chem. 2001, 66, 3663–3670. [Google Scholar] [CrossRef]
  39. Saidykhan, A.; Bowen, R.D.; Gallagher, R.T.; Martin, W.H.C. Intramolecular N-C rearrangements involving sulfonamide protecting groups. Tetrahedron Lett. 2015, 56, 66–68. [Google Scholar] [CrossRef]
  40. Saidykhan, A.; Ebert, J.; Ally, H.; Gallagher, R.T.; Martin, W.H.C.; Bowen, R.D. The scope and regioselectivity of intramolecular N-C rearrangements of orthogonally protected sulfonamides, including cyclization to saccharin derivatives. Tetrahedron Lett. 2017, 58, 3089–3091. [Google Scholar] [CrossRef]
Scheme 1. Intended and observed behaviour of orthogonally protected sulphonamide 1 derived from valine.
Scheme 1. Intended and observed behaviour of orthogonally protected sulphonamide 1 derived from valine.
Molecules 30 01823 sch001
Scheme 2. Rearrangement of ArSO2N(CH2Ph)CO2R and ArSO2N(CH2Ph)COR.
Scheme 2. Rearrangement of ArSO2N(CH2Ph)CO2R and ArSO2N(CH2Ph)COR.
Molecules 30 01823 sch002
Scheme 3. Rearrangement of orthogonally protected sulphonamides of general structure 4-XC6H4SO2N[CH(CH3)2]CO2R [39].
Scheme 3. Rearrangement of orthogonally protected sulphonamides of general structure 4-XC6H4SO2N[CH(CH3)2]CO2R [39].
Molecules 30 01823 sch003
Scheme 4. Competing rearrangement and cleavage of orthogonally protected sulphonamides of general structure 4-CH3C6H4SO2NR1CO2R2.
Scheme 4. Competing rearrangement and cleavage of orthogonally protected sulphonamides of general structure 4-CH3C6H4SO2NR1CO2R2.
Molecules 30 01823 sch004
Scheme 5. Consecutive rearrangement and cyclisation of orthogonally protected sulphonamide 4-CH3C6H4SO2N[CH(CH3)2]CO2C(CH3)3.
Scheme 5. Consecutive rearrangement and cyclisation of orthogonally protected sulphonamide 4-CH3C6H4SO2N[CH(CH3)2]CO2C(CH3)3.
Molecules 30 01823 sch005
Scheme 6. Consecutive rearrangement and cyclisation of orthogonally protected sulphonamide 4-CH3C6H4SO2N[CH(CH3)2]CO2CH3. Reagents and conditions: i, LDA, −78 °C; ii, aq. citric acid, −78 °C; iii, [(CH3)3COCO]2O, DMAP.
Scheme 6. Consecutive rearrangement and cyclisation of orthogonally protected sulphonamide 4-CH3C6H4SO2N[CH(CH3)2]CO2CH3. Reagents and conditions: i, LDA, −78 °C; ii, aq. citric acid, −78 °C; iii, [(CH3)3COCO]2O, DMAP.
Molecules 30 01823 sch006
Scheme 7. Competing rearrangement and cyclisation of orthogonally protected sulphonamides of general structure 4-XC6H4SO2NR1CO2R2.
Scheme 7. Competing rearrangement and cyclisation of orthogonally protected sulphonamides of general structure 4-XC6H4SO2NR1CO2R2.
Molecules 30 01823 sch007
Scheme 8. Synthetic routes to orthogonally protected sulphonamides of general structure 4-XC6H4SO2NR1CO2R2.
Scheme 8. Synthetic routes to orthogonally protected sulphonamides of general structure 4-XC6H4SO2NR1CO2R2.
Molecules 30 01823 sch008
Scheme 9. Mechanism for rearrangement and cyclisation of orthogonally protected sulphonamides of general structure 4-XC6H4SO2NR1CO2R2.
Scheme 9. Mechanism for rearrangement and cyclisation of orthogonally protected sulphonamides of general structure 4-XC6H4SO2NR1CO2R2.
Molecules 30 01823 sch009
Table 1. Rearrangement and cyclisation of 4-CH3C6H4SO2NR1CO2R2.
Table 1. Rearrangement and cyclisation of 4-CH3C6H4SO2NR1CO2R2.
SubstrateProducts
Relative Yield (%) aRatio a
CompoundR1R2272827:28
26aiCH3CH348521:1.1
26aiiCH3C2H567332:1
26aiiiCH3C(CH3)3≳99 b≲1≳99:1
26biC2H5CH380204:1
26biiC2H5C2H595519:1
26biiiC2H5C(CH3)3≳99 b≲1≳99:1
26ciCH2CH2CH3CH395~5~20:1
26ciiCH2CH2CH3C2H5982~50:1
26ciiiCH2CH2CH3C(CH3)3≳99 b≲1≳99:1
26diCH(CH3)2CH3~98~2~50:1
26diiCH(CH3)2C2H5≳99 b≲1≳99:1
26diiiCH(CH3)2C(CH3)3≳99 b≲1≳99:1
26eiCH2CH(CH3)2CH3≳98≳1~98:1
26eiiCH2CH(CH3)2C2H5≳99 b≲1≳99:1
26eiiiCH2CH(CH3)2C(CH3)3≳99 b≲1≳99:1
a Yields determined from the relative intensity of the relevant signals in the 1H NMR spectrum of the crude mixture of products; the quoted ratios (a measure of chemoselectivity) are the means of at least two independent reactions. Relative yield values are rounded to the nearest integer; the quoted ratio is taken from the unrounded relative yields. b Only a single product was detected by 1H NMR.
Table 2. Rearrangement and cyclisation of C6H5SO2NR1CO2R2.
Table 2. Rearrangement and cyclisation of C6H5SO2NR1CO2R2.
SubstrateProducts
Relative Yield (%) aRatio a
CompoundR1R2272827:28
26fiCH3CH390109:1
26fiiCH3C(CH3)3≳99 b≲1≳99:1
26giCH(CH3)2CH3≳99 b≲1≳99:1
26giiCH(CH3)2C2H5≳99 b≲1≳99:1
26giiiCH(CH3)2C(CH3)3≳99 b≲1≳99:1
26hiCH2CH(CH3)2CH3~982~50:1
26hiiCH2CH(CH3)2C2H5≳99 b≲1≳99:1
26hiiiCH2CH(CH3)2C(CH3)3≳99 b≲1≳99:1
a Yields determined from the relative intensity of the relevant signals in the 1H NMR spectrum of the crude mixture of products; the quoted ratios (a measure of chemoselectivity) are the means of at least two independent reactions. Relative yield values are rounded to the nearest integer; the quoted ratio is taken from the unrounded relative yields. b Only a single product was detected by 1H NMR.
Table 3. Rearrangement and cyclisation of 4-XC6H4SO2NR1CO2R2.
Table 3. Rearrangement and cyclisation of 4-XC6H4SO2NR1CO2R2.
SubstrateProducts
Relative Yield (%) aRatio a
CompoundXR1R2272827:28
26jiFCH3CH395517:1
26jiiFCH3C(CH3)399199:1
26jiiiFCH(CH3)2CH3~99~1~95:1
26jivFCH(CH3)2C2H599199:1
26jvFCH(CH3)2C(CH3)3≳99 b≲1≳99:1
26kiClCH3CH394614:1
26kiiClCH3C(CH3)3≳99 b≲1≳99:1
26kiiiClCH(CH3)2CH3~99~198:1
26kivClCH(CH3)2C2H5≳99 b≲1≳99:1
26kvClCH(CH3)2C(CH3)3≳99 b≲1≳99:1
26liBrCH3CH390109:1
26liiBrCH3C(CH3)3~99~1~99:1
26liiiBrCH(CH3)2CH3~99~1~99:1
26livBrCH(CH3)2C2H5≳99 b≲1≳99:1
26lvBrCH(CH3)2C(CH3)3≳99 b≲1≳99:1
26miCH3OCH3CH388127:1
26miiCH3OCH3C(CH3)3~99~1~99:1
26miiiCH3OCH(CH3)2CH3~99~1~99:1
26mivCH3OCH(CH3)2C2H5≳99 b≲1≳99:1
26mvCH3OCH(CH3)2C(CH3)3≳99 b≲1≳99:1
26niCF3CH3CH390109:1
26niiCF3CH3C(CH3)3≳99 b≲1≳99:1
26niiiCF3CH(CH3)2CH3~99~1~99:1
26nivCF3CH(CH3)2C(CH3)3≳99 b≲1≳99:1
26oiCNCH3CH393713:1
26oiiCNCH3C(CH3)3~99~199:1
26oiiiCNCH(CH3)2CH3≳99 b≲1≳99:1
26oivCNCH(CH3)2C2H5≳99 b≲1≳99:1
26ovCNCH(CH3)2C(CH3)3≳99 b≲1≳99:1
26piC(CH3)3CH3CH392811:1
26piiC(CH3)3CH3C(CH3)3~99~1~99:1
26piiiC(CH3)3CH(CH3)2CH3≳99 b≲1≳99:1
26pivC(CH3)3CH(CH3)2C(CH3)3≳99 b≲1≳99:1
a Yields determined from the relative intensity of the relevant signals in the 1H NMR spectrum of the crude mixture of products; the quoted ratios (a measure of chemoselectivity) are the means of at least two independent reactions. Relative yield values are rounded to the nearest integer; the quoted ratio is taken from the unrounded relative yields. b Only a single product was detected by 1H NMR.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Saidykhan, A.; Ebert, J.; Fenwick, N.W.; Martin, W.H.C.; Bowen, R.D. Steric Effects of N-Alkyl Group on the Base-Induced Nitrogen to Carbon Rearrangement of Orthogonally Protected N-Alkyl Arylsulphonamides. Molecules 2025, 30, 1823. https://doi.org/10.3390/molecules30081823

AMA Style

Saidykhan A, Ebert J, Fenwick NW, Martin WHC, Bowen RD. Steric Effects of N-Alkyl Group on the Base-Induced Nitrogen to Carbon Rearrangement of Orthogonally Protected N-Alkyl Arylsulphonamides. Molecules. 2025; 30(8):1823. https://doi.org/10.3390/molecules30081823

Chicago/Turabian Style

Saidykhan, Amie, Jenessa Ebert, Nathan W. Fenwick, William H. C. Martin, and Richard D. Bowen. 2025. "Steric Effects of N-Alkyl Group on the Base-Induced Nitrogen to Carbon Rearrangement of Orthogonally Protected N-Alkyl Arylsulphonamides" Molecules 30, no. 8: 1823. https://doi.org/10.3390/molecules30081823

APA Style

Saidykhan, A., Ebert, J., Fenwick, N. W., Martin, W. H. C., & Bowen, R. D. (2025). Steric Effects of N-Alkyl Group on the Base-Induced Nitrogen to Carbon Rearrangement of Orthogonally Protected N-Alkyl Arylsulphonamides. Molecules, 30(8), 1823. https://doi.org/10.3390/molecules30081823

Article Metrics

Back to TopTop